Chic et al. reported on a patient with lung adenocarcinoma initially had an EGFR T790M mutation but progressed to EGFR ex19del+ /T790M− /C797S+ mutation after treatment with osimertinib. The gene discussed is EGFR; the disease is lung adenocarcinoma.